This is a profile image of Michael Conway

Michael Conway

Senior PartnerPhiladelphia

Leads our global work in international development, public health, and biopharmaceuticals, helping leading organizations in public, social, and private sectors to address strategic, organizational, and operational challenges

After leading McKinsey’s Global Public Health Practice for 12 years, Michael now leads an initiative to enhance our capabilities in international development consulting across the world. He joined McKinsey in 1993, and has worked in the Chicago, Brussels, Oslo, New Jersey, and Philadelphia offices.

Michael has led numerous global healthcare projects for international institutions, with many projects focused on Africa, India, Meso-America, and China. These have spanned the breadth of issues faced by public health organizations within the government and social sector.

His public health clients have included major foundations, developing countries, multilateral institutions, bilateral donors, global funding agencies, and product development partnerships. In addition to his work with public and social sector health organizations, Michael works with a range of vaccine and biopharmaceutical clients on non-GPH-related issues of innovation and commercialization, and in the creation of business and product strategies, redesign of organizational structures, and product introductions.

He has deep experience in the development and introduction of new healthcare technologies, development of disease-focused strategies, the introduction of new vaccines, organization and performance improvement, as well as vertical programs in health systems and training.

A number of recent projects have focused on scaling up the education of healthcare professionals, and guiding governments and bilateral donors through country-level implementation programs.

  • Life Sciences
  • Social Sector

Published work

Beyond the pandemic: The next chapter of innovation in vaccines,” McKinsey & Company, May 2024

Taking off: Scaling complex manufacturing in the aerospace industry,” McKinsey & Company, February 2023

Finding solidarity in an effort to vaccinate the world,” McKinsey & Company, July 2021

A light at the end of the tunnel: US COVID-19 vaccine administration,” McKinsey & Company, April 2021

COVID-19 vaccines meet 100 million uncertain Americans,” McKinsey & Company, December 2020

An optimistic scenario for the US response to COVID-19,” McKinsey & Company, September 2020

Enabling at-scale government transformations through partner support,” McKinsey & Company, August 2019

Refueling the innovation engine in vaccines,” McKinsey & Company, May 2019

Should sub-Saharan Africa make its own drugs?,” McKinsey & Company, January 2019

Closing the tech gender gap through philanthropy and corporate social responsibility,” McKinsey & Company, September 2018

Strengthening Sub-Saharan Africa's health systems: A practical approach,” McKinsey Quarterly, June 2010

A better way to speed the adoption of vaccines,” McKinsey Quarterly, August 2008

“Addressing Africa's health workforce crisis,” McKinsey Quarterly, November 2007

“Building better partnerships for global health,” McKinsey Quarterly, December 2006


University of Chicago Law School

Texas A&M University